What are the treatment options for metastatic Melanoma

Treatment Options for Metastatic Melanoma

Metastatic melanoma means the cancer has spread beyond the original skin site to distant parts of the body. The good news is that several effective treatment approaches are now available. According to the NCCN Guidelines for Patients: Melanoma (2025), here's what you should know about your options:

Primary Treatment Approaches

1. Systemic Therapy (Drugs That Work Throughout the Body)

Systemic therapy is typically the preferred initial treatment for metastatic melanoma. This includes two main categories:

Immunotherapy - Checkpoint Inhibitors: These drugs work by "releasing the brakes" on your immune system. Your body's T cells (immune cells) naturally fight cancer, but tumor cells can hide by blocking these T cells. Checkpoint inhibitors remove that block, allowing your immune system to attack the cancer.

Common checkpoint inhibitors include:

• Pembrolizumab (Keytruda)
• Nivolumab (Opdivo) - now available in a new subcutaneous (under-the-skin) injectable form called Opdivo Qvantig, which can be given every 2-4 weeks

According to NCCN Guidelines, these are often used as first-line treatments because they can be effective for many patients.

Targeted Therapy: If your melanoma has a BRAF V600 mutation (a specific genetic change found in some melanomas), you may be eligible for targeted therapy:

• Dabrafenib/trametinib - this combination targets the specific mutation driving your cancer cells

Your doctor will test your tumor for BRAF mutations to determine if this option applies to you.

2. Combination Immunotherapy

Sometimes doctors combine different immunotherapy drugs:

• Ipilimumab may be combined with anti-PD-1 therapies (like nivolumab or pembrolizumab) for patients who haven't received prior immunotherapy

This combination can be more powerful but may also have more side effects.

3. Local and Regional Treatment Options

Even with metastatic disease, local treatments may be used alongside systemic therapy:

Intralesional Therapy (T-VEC):

• Talimogene laherparepvec (T-VEC) is a specially modified virus injected directly into melanoma tumors in the skin or lymph nodes
• It infects and kills cancer cells while avoiding healthy cells
• This is preferred for accessible tumors

Radiation Therapy:

• Stereotactic radiosurgery (SRS) - a single high-dose radiation treatment, often preferred for brain metastases
• Stereotactic radiotherapy (SRT) - similar to SRS but given in 1-5 sessions
• Intensity-modulated radiation therapy (IMRT) - uses multiple beams of different strengths to target tumors while protecting surrounding tissue

Regional Chemotherapy:

• Isolated limb infusion/perfusion (ILI/ILP) - a specialized procedure where high-dose chemotherapy is delivered directly to an arm or leg affected by melanoma. This should only be done at centers experienced with this technique.

4. Surgery

Surgery may still play a role in metastatic melanoma:

• Removing individual metastatic tumors (especially if there are only a few)
• Often combined with systemic therapy rather than used alone

5. Supportive Care (Palliative Care)

This focuses on managing symptoms and side effects to maintain quality of life, regardless of which treatment you choose.

How Doctors Decide Which Treatment to Use

According to NCCN Guidelines, your oncologist will consider:

• Where the cancer has spread (brain, lungs, liver, other organs)
• Number of metastases (single vs. multiple tumors)
• BRAF mutation status (whether your tumor has this genetic change)
• Prior treatments you've received
• Your overall health and ability to tolerate treatment
• Your preferences regarding side effects and treatment schedule

Important Questions to Ask Your Oncologist

1. Does my tumor have a BRAF mutation? (This determines if targeted therapy is an option)
2. What is the preferred first-line treatment for my specific situation?
3. Am I eligible for immunotherapy, and if so, which type?
4. What are the expected side effects of the treatment you're recommending?
5. How will we measure if the treatment is working? (imaging scans, blood tests, etc.)
6. Are there clinical trials available for my type of metastatic melanoma?
7. If my first treatment doesn't work well, what are the next options?
8. How often will I need treatment, and what does the schedule look like?

Clinical Trials

Everyone with metastatic melanoma should consider clinical trials, which test newer approaches. You can search for trials at:

• NCI (National Cancer Institute): cancer.gov/about-cancer/treatment/clinical-trials/search
• ClinicalTrials.gov: clinicaltrials.gov

Key Takeaway

Metastatic melanoma is serious, but modern treatments—especially immunotherapy and targeted therapy—have significantly improved outcomes for many patients. Your specific treatment plan will be personalized based on your tumor's characteristics, your health status, and your goals for care.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.